PTSD Trial, Recruiting (NCT06037785)

PTSD Trial, Recruiting NCT06037785 Sponsor: University of Washington Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06037785 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had an ICD (a small device implanted in the chest to help control dangerous heart rhythms) fitted to reduce the risk of sudden cardiac arrest
People who have received at least one shock from their ICD in the week before joining the study, whether the shock was triggered correctly or not
People who are able to read, speak, and write in English
People who have access to the internet and a telephone for the length of the study

Who may not be able to join:

People who currently have a diagnosis of PTSD, schizophrenia, or bipolar disorder
People who score above 6 on a short memory and thinking test called the Short BLESSED test, which may suggest significant difficulties with memory or thinking
People who are under 18 years of age
People who score 4 or higher on a standard alcohol use screening tool called the AUDIT-C, which suggests a higher level of alcohol consumption
People who regularly use illicit drugs for non-medical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cynthia M Dougherty, ARNP, PhD, University of Washington

Phone: 206 221-7927

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06037785

Sponsor: University of Washington

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: 206 221-7927

More information: https://clinicaltrials.gov/study/NCT06037785

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had an ICD (a small device implanted in the chest to help control dangerous heart rhythms) fitted to reduce the risk of sudden cardiac arrest
People who have received at least one shock from their ICD in the week before joining the study, whether the shock was triggered correctly or not
People who are able to read, speak, and write in English
People who have access to the internet and a telephone for the length of the study

Who may not be able to join:

People who currently have a diagnosis of PTSD, schizophrenia, or bipolar disorder
People who score above 6 on a short memory and thinking test called the Short BLESSED test, which may suggest significant difficulties with memory or thinking
People who are under 18 years of age
People who score 4 or higher on a standard alcohol use screening tool called the AUDIT-C, which suggests a higher level of alcohol consumption
People who regularly use illicit drugs for non-medical reasons

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Washington

Registry

ClinicalTrials.gov

Start date

1 October 2024

Est. completion

31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

ICD Shock anxiety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov